Key Takeaways
- Goldman Sachs reached record highs on strong earnings, while several "Mag 7" stocks struggled in 2026.
- The competitive landscape for GLP-1 weight loss drugs is intensifying, with new oral treatments emerging.
- The semiconductor sector is surging, propelled by TSMC's 35% earnings growth and a significant U.S.-Taiwan chip supply chain deal.
- Political proposals, including a potential credit card rate cap, are influencing bank stock performance.
- The Japanese Yen is at 18-month lows against the dollar, potentially boosting Japanese equities and exporters.
Deep Dive
- Goldman Sachs stock hit record highs, driven by strong earnings and its capital markets business.
- Conversely, "Mag 7" stocks, including Meta, Microsoft, and Apple, largely underperformed in 2026, with some showing declines.
- Panelists debated Goldman's earnings growth and favorable market conditions against the perceived lack of recent performance and potential price compression in cloud and chip sectors for Mag 7 stocks.
- One panelist cited Goldman Sachs' strong earnings, capital markets business, and favorable yield curve dynamics as reasons for optimism.
- Financial institutions, including banks, are perceived as having matured into better risk managers.
- This improved risk management is expected to reduce the likelihood of severe earnings drawdowns in the absence of exogenous events.
- Discussion covered bank balance sheets, cash positions, and potential leverage within sales and trading businesses.
- The political season is accelerating, with progressive proposals such as potential credit card rate caps impacting various sectors.
- Bank stocks experienced poor performance earlier in the week, partially attributed to a proposed 10% credit card cap.
- While many proposals are introduced, their implementation is expected to take time due to the legislative process.
- Regional banks are highlighted; their balance sheets have greater exposure to commercial real estate than credit cards, and the NASDAQ Bank Index is at 50-year lows relative to the Russell 2000.
- Taiwan Semiconductor Manufacturing Company (TSMC) shares surged after reporting a 35% earnings increase and plans for increased spending.
- A U.S.-Taiwan deal aims to bring 40% of Taiwan's chip supply chain to America with at least $250 billion in spending over three years.
- ASML stock also saw a significant rise, driven by broader gains within the semiconductor sector.
- The equal-weight SOX index's performance suggests semiconductors are recouping relative losses since the dot-com peak.
- The Dow, S&P, and NASDAQ indices showed gains following recent losses.
- Crude oil prices dropped 4.5% after indications that unrest in Iran was subsiding.
- A panelist maintained a neutral outlook on oil prices but noted that energy stocks, including services, refiners, and integrated companies, are poised for growth.
- Structure Therapeutics' oral GLP-1 pill has demonstrated competitive data against established players like Eli Lilly and Novo Nordisk.
- Eli Lilly's stock dropped after the FDA delayed a decision on their obesity pill, extending the timeline to April 10th.
- Structure Therapeutics' stock has surged since December 8th, driven by positive data on its oral GLP-1 pill.
- CEO Ray Stevens emphasized the vast, unmet need in the global obesity market, projecting billions affected by 2030.
- Structure Therapeutics holds $1.5 billion in capital, providing funding until the end of 2028 to complete its phase three chronic weight management study for elenogliparon.
- The company is also advancing ACCG 2671, an oral amylin molecule, identified as a key target in the obesity space.
- A company representative dismissed concerns about market competition, citing historical examples where later entrants captured significant market share in broad markets like statins.
- Confidence was expressed in a "best-in-class" strategy based on efficacy, safety, manufacturing, and combinability for their oral small molecule drugs.
- The Japanese Yen is trading near 18-month lows against the dollar, prompting observation for potential intervention by the Bank of Japan.
- Charts indicate that the Yen's upward movement signifies weakness, potentially signaling a significant bottom or further decline.
- A weaker Yen is considered beneficial for Japanese exporters.
- Potential fiscal stimulus, increased bond yields, buybacks, and earnings growth make Japanese equities an attractive investment.